Applied Biosystems Inc. has commercialized an analysis system to enable researchers to perform high-sample-throughput genotyping studies. The TaqMan OpenArray genotyping system provides life scientists with Applied Biosystems’ TaqMan SNP genotyping assays and TaqMan DME assays in a flexible format.
Researchers using this integrated platform can experience an end-to-end genotyping workflow of less than eight hours. Single nucleotide polymorphism (SNP) genotyping studies can also be performed on this platform. The TaqMan OpenArray genotyping system will provide researchers and commercial organization with a validation and screening tool that has the potential to improve genotyping efficiencies and simplify their workflows, according to the company.
The TaqMan OpenArray genotyping system enables researchers to perform studies that investigate SNPs across thousands to tens of thousands of samples.
The TaqMan OpenArray genotyping plates provide researchers with the flexibility to deploy assays in many different configurations. Each TaqMan OpenArray genotyping plate contains 3,072 through-holes arranged in 48 sub-arrays of 64 through-holes each.
The system includes an instrument platform, reagents, and consumables, with the main components consisting of the TaqMan OpenArray genotyping instrument platform and TaqMan OpenArray genotyping plates that are pre-loaded with pre-designed or custom TaqMan SNP genotyping or drug metabolizing enzyme (DME) assays.
Filed Under: Drug Discovery
